Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10051913HBVENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS30007496HIVENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS30007497HIVENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS30048625HIVENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS30020480HIVENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS30017649HIVENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS20027059HPVENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS44005691HTLV-1ENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS44013933HTLV-1ENSG00000196218.15protein_codingRYR1NoNo6261P21817
TVIS44024002HTLV-1ENSG00000196218.15protein_codingRYR1NoNo6261P21817
TCGA Plot Options
Drug Information
GeneRYR1
DrugBank IDDB04786
Drug NameSuramin
Target IDBE0000739
UniProt IDP21817
Regulation Typeagonist
PubMed IDs16056233
CitationsWolner I, Kassack MU, Ullmann H, Karel A, Hohenegger M: Use-dependent inhibition of the skeletal muscle ryanodine receptor by the suramin analogue NF676. Br J Pharmacol. 2005 Oct;146(4):525-33.
GroupsInvestigational
Direct ClassificationBenzanilides
SMILESCC1=C(NC(=O)C2=CC(NC(=O)NC3=CC=CC(=C3)C(=O)NC3=C(C)C=CC(=C3)C(=O)NC3=C4C(C=C(C=C4S(O)(=O)=O)S(O)(=O)=O)=C(C=C3)S(O)(=O)=O)=CC=C2)C=C(C=C1)C(=O)NC1=C2C(C=C(C=C2S(O)(=O)=O)S(O)(=O)=O)=C(C=C1)S(O)(=O)=O
Pathways
PharmGKBPA10292
ChEMBLCHEMBL265502